KEYSHA NABOURS: Open Payments
NPI 1932450210 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 39 payments from 14 companies in 2025. Trend: 2023 $1,029 · 2024 $874 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $271 |
| PFIZER INC. | 2 | $209 |
| Axsome Therapeutics, Inc. | 6 | $198 |
| Ardelyx, Inc. | 2 | $147 |
| AstraZeneca Pharmaceuticals LP | 3 | $146 |
| Amgen Inc. | 12 | $139 |
| Abbott Laboratories | 1 | $131 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $112 |
| Novo Nordisk Inc | 1 | $31 |
Products named: JARDIANCE, NURTEC ODT, Auvelity, IBSRELA, FREESTYLE LIBRE 3, JOURNAVX, XIFAXAN, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
